Drug
Hmpl A251
Hmpl A251: highest development phase Phase 1/2, developed by Hutchmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Hutchmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| HMPL-A251 NCT07228247 | Phase 1/2 | Solid Tumors, Adult |
Latest
No recent events.
Follow Hmpl A251 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.